Skip to main content

Table 3 Log rank analysis

From: Megaprostheses for the revision of infected hip arthroplasties with severe bone loss

Outcome

Compared groups

Survival at 2 years (CI95%)

Survival at 5 years (CI95%)

p-value

Infection free survival

Coated

91.7% (53.9–98.8)

80.2% (40.2–94.8)

0.17

Uncoated

100% (100–100)

100% (100–100)

Uncoated

100% (100–100)

100% (100–100)

0.22

PorAg®

100% (100–100)

100% (100–100)

DAC®

100% (100–100)

66.7% (5.4–94.5)

PorAg® + DAC®

75% (12.8–96.1)

75% (12.8–96.1)

Cemented

100% (100–100)

100% (100–100)

0.50

Cementless

94.1% (65–99.2)

87.4% (58.1–96.7)

Major revision free survival

Coated

91.7% (53.9–98.8)

91.7% (53.9–98.8)

0.97

Uncoated

100% (100–100)

88.9% (43.3–98.4)

Uncoated

100% (100–100)

88.9% (43.3–98.4)

0.29

PorAg®

100% (100–100)

100% (100–100)

DAC®

66.7% (5.4–94.5)

66.7% (5.4–94.5)

PorAg® + DAC®

100% (100–100)

100% (100–100)

Cemented

75% (12.8–96.1)

75% (12.8–96.1)

0.19

Cementless

100% (100–100)

92.3% (56.6–98.9)

Overall revision free survival

83.35 (50.7–93.94)

83.35 (50.7–93.94)

Â